Advanced Search

Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2013 April;104(2) > Minerva Medica 2013 April;104(2):155-60

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA MEDICA

A Journal on Internal Medicine

Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,913

Frequency: Bi-Monthly

ISSN 0026-4806

Online ISSN 1827-1669

Minerva Medica 2013 April;104(2):155-60

THROMBOSIS 

Myeloma and thrombotic complications

Tzoran I. 1, Brenner B. 1, 2, Hoffman R. 1, 2

1 Department of Hematology and Bone Marrow Transplantation Rambam Health Care Campus, Haifa, Israel;
2 Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel

Multiple myeloma (MM) is a hematological malignancy with high risk for thrombosis. While venous thromboembolism is more common, myeloma patients can also present with arterial thrombosis. Risk factors responsible for this complication can be patient-related, myeloma- and treatment-related. Thromboprophylaxis is indicated along with specific therapeutic regimens employed in myeloma patients. This review will cover potential risk factors for thrombosis in patients with multiple myeloma, prevention recommendations and treatment strategies in this clinical setting.

language: English


FULL TEXT  REPRINTS

top of page